MRCPUK SEND Endocrinology and Diabetes (Specialty Certificate Examination) Online Training
MRCPUK SEND Online Training
The questions for SEND were last updated at Feb 18,2025.
- Exam Code: SEND
- Exam Name: Endocrinology and Diabetes (Specialty Certificate Examination)
- Certification Provider: MRCPUK
- Latest update: Feb 18,2025
A 29-year-old woman presented with primary infertility, having had unprotected sexual intercourse for 15 months. Menarche had occurred at the age of 13.5 years. Her menstrual cycle was irregular, occurring every 20C60 days. There was no history of galactorrhoea. She denied abnormal hair growth.
On examination, her body mass index was 28.9 kg/m2 (18C25) and she had normal secondary sexual characteristics. Her visual fields were full to confrontation.
Investigations:
serum androstenedione12.8 nmol/L (0.6C8.8)
serum oestradiol205 pmol/L (200C400)
serum testosterone2.4 nmol/L (0.5C3.0)
serum sex hormone binding globulin23 nmol/L (40C137)
serum follicle-stimulating hormone4.3 U/L (2.5C10.0)
serum luteinising hormone8.5 U/L (2.5C10.0)
serum prolactin420 mU/L (<360)
hysterosalpingogrampatent fallopian tubes
partner’s semen analysisnormal sperm count and motility
What is the most appropriate first-line intervention?
- A . cabergoline
- B . human chorionic gonadotropin
- C . human menopausal gonadotropins
- D . metformin
- E . orlistat
A 66-year-old woman was admitted with carpopedal spasm. During the previous week she had had 2 days of diarrhoea following treatment with ciprofloxacin for a urinary tract infection. She had long-standing rheumatoid arthritis treated with prednisolone 5 mg daily, and was also taking alendronic acid, omeprazole and furosemide.
Investigations:
serum creatinine115 ?mol/L (60C110)
serum corrected calcium1.79 mmol/L (2.20C2.60)
serum alkaline phosphatase124 U/L (45C105)
serum magnesium0.26 mmol/L (0.75C1.05)
plasma parathyroid hormone2.7 pmol/L (0.9C5.4)
Which medicine is most likely to be responsible for her metabolic derangement?
- A . alendronic acid
- B . ciprofloxacin
- C . furosemide
- D . omeprazole
- E . prednisolone
A 48-year-old man presented with gynaecomastia. His serum oestradiol was increased and
a CT scan of adrenal glands revealed a 13-cm tumour of the left adrenal gland. Further workup showed increased secretion of 17-hydroxyprogesterone, cortisol and androstenedione. A diagnosis of adrenocortical carcinoma was suspected.
Investigations:
staging CT scan of chest and abdomenno evidence of metastasis
What is the most appropriate next step in management?
- A . adrenal fine-needle biopsy
- B . iodocholesterol scan
- C . left adrenalectomy followed by adjuvant combination chemotherapy
- D . left adrenalectomy followed by adjuvant mitotane treatment
- E . MR scan of adrenal glands with chemical shift analysis
An 18-year-old man with cystic fibrosis was referred to clinic. Over recent months his lung function had deteriorated and he had lost weight. He was being treated for a chest infection at the time of the consultation.
Investigations:
oral glucose tolerance test (75 g):
fasting plasma glucose8.2 mmol/L (3.0C6.0)
2-h plasma glucose13.5 mmol/L (<7.8)
What is the most appropriate management?
- A . repeat oral glucose tolerance test after chest infection has resolved
- B . restrict refined carbohydrate intake
- C . start gliclazide
- D . start insulin
- E . start sitagliptin
A 55-year-old man presented with a 3-year history of increasing pain in the right hip. He had been otherwise well and was taking no medication. He was reluctant to consider any intravenous treatment as he had a phobia of needles.
Investigations:
X-ray of hipssclerotic bone in right pubis and ischium
suggestive of Paget’s disease
What is the most appropriate oral treatment?
- A . calcium and vitamin D
- B . ibandronate sodium
- C . risedronate sodium
- D . sodium clodronate
- E . strontium ranelate
A 26-year-old woman was urgently referred to clinic with a 6-week history of retroorbital headaches and deteriorating vision. Her past medical history was unremarkable, although on questioning she admitted that she had recently found it increasingly difficult to cope with her busy job.
On examination, her pulse was 60 beats per minute and regular, and her blood pressure was 110/75 mmHg lying and 90/60 mmHg standing. She was pale and had dry skin. Visual acuities were reduced (6/12 right; 6/24 left), and she had a bitemporal inferior quadrantanopia.
Investigations:
serum sodium132 mmol/L (137C144)
serum potassium4.0 mmol/L (3.5C4.9)
short tetracosactide Synacthen® test (250 micrograms):
serum cortisol (30 min after tetracosactide)185 nmol/L (>550)
plasma follicle-stimulating hormone2.7 U/L
plasma luteinising hormone3.5 U/L
serum prolactin1050 mU/L (<360)
serum thyroid-stimulating hormone0.3 mU/L (0.4C5.0)
serum free T48.0 pmol/L (10.0C22.0)
serum insulin-like growth factor 14.7 nmol/L (7.5C37.3)
MR scan of brainsee image
What is the most likely diagnosis?
- A . autoimmune hypophysitis
- B . craniopharyngioma
- C . non-functioning pituitary adenoma
- D . prolactinoma
- E . Rathke’s cleft cyst
A 23-year-old woman was found to have type 1 diabetes mellitus following a short history of polyuria, polydipsia and unintentional weight loss. She started taking insulin aspart before meals and insulin detemir daily.
What is the most appropriate time from diagnosis to start screening for microalbuminuria?
- A . 1 year
- B . 2 years
- C . 5 years
- D . 10 years
- E . immediately
A 64-year-old man presented with palpitations, fatigue and malaise. Two months previously, he had sustained an acute myocardial infarction complicated by ventricular tachycardia and cardiac arrest, and had been discharged taking amiodarone 200 mg daily.
On examination, he appeared well, his pulse was 90 beats per minute and regular, and he had mild tremor of his hands but no other abnormal signs.
Investigations:
serum thyroid-stimulating hormone6.2 mU/L (0.4C5.0)
serum free T418.2 pmol/L (10.0C22.0)
serum free T34.8 pmol/L (3.0C7.0)
What is the most appropriate next step in management?
- A . discontinue amiodarone
- B . isotope scan of thyroid
- C . repeat thyroid function tests in 2 months
- D . repeat thyroid function tests in 12 months
- E . start levothyroxine
A 64-year-old woman presented with features of acromegaly. An MR scan showed a pituitary tumour with cavernous sinus extension. She underwent trans-sphenoidal surgery and histology of the pituitary tissue showed numerous cells immunostaining for growth hormone.
Investigations (6 months postoperatively):
MR scan of pituitaryenlarged sella, residual tumour in right cavernous sinus
serum growth hormone (day curve average)3.2 ?g/L (<2)
serum insulin-like growth factor 142.0 nmol/L (3.3C23.3)
What is the most appropriate next step in management?
- A . conventional external beam radiotherapy to pituitary region
- B . long-acting octreotide
- C . pegvisomant
- D . repeat trans-sphenoidal surgery
- E . watchful waiting
A 17-year-old Caucasian girl presented with primary amenorrhea.
On examination, her body mass index was 21 kg/m2 (18C25). Her body habitus was normal and she had appropriate breast development. There was no hirsutism or acne.
Investigations:
serum oestradiol<180 pmol/L (200C400)
serum testosterone31.7 nmol/L (0.5C3.0)
serum follicle-stimulating hormone4.0 U/L (2.5C10.0)
serum luteinising hormone6.0 U/L (2.5C10.0)
What is the most likely diagnosis?
- A . adrenocortical carcinoma
- B . androgen-secreting ovarian tumour
- C . complete androgen insensitivity syndrome
- D . ovarian hyperthecosis
- E . polycystic ovary syndrome